Usefulness of Presepsin (Soluble CD14 Subtype) as a Diagnostic Marker of Sepsis in Egyptian Patients with Acute Myeloid Leukemia

Journals Menu

Follow SCIRP

ISSN Print: 2161-6620
ISSN Online: 2161-6663
www.scirp.org/Journal/ajmb
E-mail: ajmb@scirp.org

Citations h5-index & Ranking*

"Usefulness of Presepsin (Soluble CD14 Subtype) as a Diagnostic Marker of Sepsis in Egyptian Patients with Acute Myeloid Leukemia"
written by Maged Maurice, Dalia Nafea, Mohamed El Sawy, Rania Soelam, Sylvia Youssef,
published by American Journal of Molecular Biology, Vol.4 No.4, 2014

has been cited by the following article(s):

[1]	БЕЛКИ ОСТРОЙ ФАЗЫ ВОСПАЛЕНИЯ: ДИАГНОСТИЧЕСКОЕ И ПРОГНОСТИЧЕСКОЕ ЗНАЧЕНИЕ
	2022

[2]	Diagnosis of Sepsis among Adult Patients with AML Using Scd14
	2021

[3]	Nötropenik hastalarda presepsin düzeyi ile bakteriyel enfeksiyonun değerlendirilmesi
	2020

[4]	The predictive value of procalcitonin, C-reactive protein, presepsin, and soluble-triggering receptor expressed on myeloid cell levels in bloodstream infections in …
	2019

[5]	Validity of biomarkers in screening for neonatal sepsis–A single center–hospital based study
	Pediatrics & Neonatology, 2018

[6]	МЕСТО ПРЕСЕПСИНА В СКРИНИНГЕ ИНФЕКЦИИ У ПАЦИЕНТОВ В КРИТИЧЕСКОМ СОСТОЯНИИ
	2018

[7]	Značaj određivanja solubilnog CD14 podtipa-presepsina u trahealnom aspiratu u diferencijalnoj dijagnozi infekcije novorođenčeta
	2018

[8]	Place of presepsin in the screening for infections in the critically ill patients
	2018

[9]	Применение мультипотентных мезенхимных стромальных клеток для лечения септического шока у больных в состоянии агранулоцитоза
	2016

[10]	PRESEPSIN LEVELS AT NEUTROPENIC PATIENTS

Follow SCIRP

[1]	Validity of biomarkers in screening for neonatal sepsis – A single center –hospital based study Pediatrics & Neonatology, 2018 DOI:10.1016/j.pedneo.2018.05.001

[2]	PLACE OF PRESEPSIN IN THE SCREENING FOR INFECTIONS IN THE CRITICALLY ILL PATIENTS Messenger OF ANESTHESIOLOGY AND RESUSCITATION, 2018 DOI:10.21292/2078-5658-2018-15-4-23-33